35
Views
1
CrossRef citations to date
0
Altmetric
Device Profile

GreenLight™ laser in the treatment of lower urinary tract symptoms due to benign prostatic enlargement

, , &
Pages 139-147 | Published online: 09 Jan 2014

References

  • Madersbacher S, Alivizatos G, Nordling J et al. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur. Urol.46, 547–554 (2004).
  • Iriarte AL, Ruiz de la Illa NS, Urzaiz MU. Which is the gold standard in BPH surgery? Arch. Esp. Urol.62, 93–95 (2009).
  • Gupta NP, Anand A. Comparison of TURP, TUVRP, and HoLEP. Curr. Urol. Rep.10, 276–278 (2009).
  • Ruszat R, Seitz M, Wyler SF et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur. Urol.54, 893–901 (2008).
  • Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur. Urol.52, 1456–1463 (2007).
  • Gupta N, Sivaramakrishna, Kumar R et al. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int.97, 85–89 (2006).
  • Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur. Urol.53, 160–166 (2008).
  • Elzayat EA, Elhilali MM. Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur. Urol.52, 1465–1471 (2007).
  • Rajbabu K. GreenLight photoselective vaporization of prostate – a technical review. Prostate Cancer Prostatic Dis.10, S6–S9 (2007).
  • Fu WJ, Hong BF, Wang XX et al. Evaluation of GreenLight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J. Androl.8, 367–371 (2006).
  • Sountoulides P, Tsakiris P. The evolution of KTP laser vaporization of the prostate. Yonsei Med. J.49, 189–199 (2008).
  • Alemu MH. Transurethral resection of the prostate (TURP) – in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia. Ethiop. Med. J.47, 65–69 (2009).
  • Gomez-Sancha F, Muir G, Bachmann A et al. Green light HPS laser prostatectomy: recommendations on surgical technique. Eur. Urol. Video J.15.1, 5 (2010).
  • Heinrich E, Schiefelbein F, Schoen G. Technique and short-term outcome of green light laser (KTP, 80W) vaporisation of the prostate. Eur. Urol.52, 1632–1637 (2007).
  • Te AE. Current state of the art photoselective vaporization prostatectomy: laser therapy for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis.10, S2–S5 (2007).
  • Heinrich E, Wendt-Nordahl G, Honeck P et al. 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J. Endourol.24, 75–79 (2010).
  • Woo H, Reich O, Bachmann A et al. Outcome of GreenLight HPS120-W laser therapy in specific patient populations: those in retention,on anticoagulants, and with large prostates (>80 ml). Eur. Urol. Suppl.7, 378–383 (2008).
  • Ruszat R, Wyler S, Forster T et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur. Urol.51, 1031–1038 (2007).
  • Horasanli K, Silay MS, Altay B et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 ml: a short-term prospective randomized trial. Urology71, 247–251 (2008).
  • Pfitzenmaier J, Gilfrich C, Pritsch M et al. Vaporization of prostates of > or =80 ml using a potassium–titanyl–phosphate laser: midterm-results and comparison with prostates of <80 ml. BJU Int.102, 322–327 (2008).
  • Bachmann A, Schurch L, Ruszat R et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur. Urol.48, 965–971 (2005).
  • Volkan T, Ihsan TA, Yilmaz O et al. Short term outcomes of high power (80 W) potassium–titanyl–phosphate laser vaporization of the prostate. Eur. Urol.48, 608–613 (2005).
  • Bouchier-Hayes D, Van Appledorn S, O’Malley PJ, Bugeja P, Costello AJ. A randomised trial of photoselective vaporization of the prostate (PVP) using the GreenLight laser versus transurethral prostatectomy (TURP) with one year follow-up. J. Urol. Suppl.179, 630 (2008).
  • Alivizatos G, Skolarikos A, Chalikopoulos D et al. 80W PVP versus TURP: results of a randomised prospective study at 12 months of follow-up. Eur. Urol. Suppl.7, 202 (2008).
  • Seki N, Nomura H, Yamaguchi A et al. Effects of photoselective vaporization of the prostate on urodynamics in patients with benign prostatic hyperplasia. J. Urol.180, 1024–1028 (2008).
  • Reich O, Bachman A, Choi B et al. International multicentre experience of the GreenLight HPS 120 W laser in patients with symptomatic BPH. Eur. Urol. Suppl.7, 202 (2008).
  • Son H, Ro YK, Min SH et al. Modified vaporization-resection for photoselective vaporization of the prostate using a GreenLight High-Performance System 120-W laser: the Seoul technique. Urology77(2), 427–432 (2010).
  • Bouchier-Hayes DM, Van Appledorn S, Bugeja P et al. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium–titanyl–phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int.105, 964–969 (2010).
  • Park JH, Son H, Paick JS. Comparative analysis of the efficacy and safety of photoselective vaporization of the prostate for treatment of benign prostatic hyperplasia according to prostate size. Korean J. Urol.51, 115–121 (2010).
  • Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium–titanyl–phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J. Urol.174, 1344–1348 (2005).
  • Te AE, Malloy TR, Stein BS et al. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int.97, 1229–1233 (2006).
  • Tugcu V, Tasci AI, Sahin S et al. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J. Endourol.22, 1519–1525 (2008).
  • Al-Ansari A, Younes N, Sampige VP et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur. Urol.58, 349–355 (2010).
  • Spaliviero M, Araki M, Culkin DJ et al. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J. Endourol.23, 495–502 (2009).
  • Kaplon DM, Iannotti H. Prostatic capsular perforation with extravasation resulting in pubic osteomyelitis: a rare complication of KTP laser prostatectomy. J. Endourol.22, 2705–2706 (2008).
  • Bouchier-Hayes DM, Anderson P, Van Appledorn S et al. KTP laser versus transurethral resection: early results of a randomized trial. J. Endourol.20, 580–585 (2006).
  • Ruszat RS, Seifert HH, Wyler S, Forster T, Leippold T, Bachmann A. Photoselective vaporization (PVP) vs. transurethral electroresection of the prostate (TURP): a comparative cost analysis. Eur. Urol. Suppl.5, 271 (2006).
  • Stovsky MD, Griffiths RI, Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J. Urol.176, 1500–1506 (2006).
  • Goh AC, Gonzalez RR. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis. J. Urol.183, 1469–1473 (2010).
  • de la Rosette J, Alivizatos G. Lasers for the treatment of bladder outlet obstruction: are they challenging conventional treatment modalities? Eur. Urol.50, 418–420 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.